by clearskymd | Oct 31, 2019 | Parkinson's
Levodopa is one of the main medications used to treat symptoms of Parkinson’s. As Parkinson’s progresses the doses of levodopa needed to maintain control over symptoms increases. Dyskinesia is a complication of long-term levodopa use in people who have had...
by clearskymd | Oct 30, 2019 | Company News
ClearSky Medical Diagnostics is thrilled to announce that two LID-Monitors, designed to help people with Parkinson’s control their condition, have been acquired at a hospital in Leeds. Leeds Teaching Hospitals provides a comprehensive service for patients with...
by clearskymd | Jul 2, 2019 | Company News
A research paper describing some of the experimental work being undertaken in the development of ClearSky’s CF-Monitor will be presented at the MedGEC Workshop 2019 in Prague in July. The MedGEC Workshop focusses on the application of genetic and evolutionary...
by clearskymd | Jun 26, 2019 | Company News
ClearSky will showcase its technology and products at an international summit of medical innovators at Nanjing Tech Week in China. Hosted by the Nanjing Municipal Government, Nanjing Tech Week explores the latest technology innovation and trends in a series of...
by clearskymd | Jun 20, 2019 | Company News
ClearSky Medical Diagnostics has forged a partnership with Shimmer Research – a leading provider of wearable wireless sensing solutions – to bring a new level of analytic capabilities to the use of wearable sensors in clinical research. The partnership will combine...
Recent Comments